Performance assessment of a direct steam solar power plant with hydrogen energy storage: An exergoeconomic study

Power generation and its storage using solar energy and hydrogen energy systems is a promising approach to overcome serious challenges associated with fossil fuel-based power plants. In this study, an exergoeconomic model is developed to analyze a direct steam solar tower-hydrogen gas turbine power plant under different operating conditions. An on-grid solar power plant integrated with a hydrogen storage system composed of an electrolyser, hydrogen gas turbine and fuel cell is considered. When solar energy is not available, electrical power is generated by the gas turbine and the fuel cell utilizing the hydrogen produced by the electrolyser. The effects of different working parameters on the cycle performance during charging and discharging processes are investigated using thermodynamic analysis. The results indicate that increasing the solar irradiation by 36%, leads to 13% increase in the exergy efficiency of the cycle. Moreover, the mass flow rate of the heat transfer fluid in solar system has a considerable effect on the exergy cost of output power. Solar tower has the highest exergy destruction and capital investment cost. The highest exergoeconomic factor for the integrated cycle is 60.94%. The steam turbine and PEM electrolyser have the highest share of exergoeconomic factor i.e., 80.4% and 50%, respectively.     

A model of PEMFC-battery system to evaluate inner operating status and energy consumption under different energy management strategies

A hybrid system with jointed battery and PEMFC is popular and of great potential in New Energy Vehicle (NEV) application. However, reliability and efficiency remain to be improved for commercial products. To reflect the complicated physics inside the proton exchange membrane fuel cell (PEMFC), the PEMFC model consisting of inner muti-physics process and other accessories was built, then a complete hybrid system was established when a matched battery, DC/DC, regenerative braking were taken into consideration. Based on the above model, the stack state and system performance under standard cycle for heavy duty vehicle-CWTVC were obtained. According to the simulation results, fuel cell states such as pressure, water content and voltage suffers severe oscillation with external load, especially in the highway cycle. Membrane electrode assembly (MEA) suffers from pressure impact with average value of more than 24 kPa in highway cycle. In the aspect of relative humidity, the PEMFC stack is most threatened in road cycle. As for the hybrid system, its efficiency and state of charge (SOC) fluctuation perform worst in urban cycle and road cycle respectively, while its highest efficiency occurs in road test. Operating mode of fuel cell has influence on hybrid system. When 3-level mode of fuel cell output was applied, the efficiency increased to its peak value at medium level of 28 kW and then declined gradually. H₂ consumption had an opposite trend compared to efficiency. In the aspect of battery SOC, it declines in operating process and its fluctuations decreases when medium level got bigger. The 3-level mode and 4-level mode were compared using this model. It can be concluded that although 3-level mode performs slightly better in hybrid system efficiency, H₂ consumption, pressure impact, it does not have absolute advantage over 4-level mode in other indicators.     

Simulation of hydrogen and coal gas fueled flat-tubular solid oxide fuel cell (FT-SOFC)

Solid oxide fuel cells (SOFCs) are considered an important technology in terms of high efficiency and clean energy generation. Flat-tubular solid oxide fuel cell (FT-SOFC) which is a combination of tubular and planar cell geometries stands out with its performance values and low costs. In this study, the performance of an FT-SOFC is analyzed numerically by using finite element method-based design as a result of changing parameters by using different fuels which are pure hydrogen and coal gas with various proportions of CO. In addition, cell performance values for different temperatures were analyzed and interpreted. Analyzes have been performed by using COMSOL Multiphysics software. The rates of CO composition used are 10%, 20%, and 40%, respectively. In addition, the air was used as the oxidizer in all cases. The cell voltage and average cell power of the FT-SOFC were examined under the 800 °C operating condition. The maximum power value and current density value were obtained as 710 W/m² and 1420 A/m² for the flat-tubular cell, respectively. As a result of the study, it was observed that the maximum cell power densities increased with increasing temperature. Analysis results showed that FT-SOFCs have suitable properties for different fuel usage and different operating temperatures. High-performance values and design features in different operating conditions are expected to make FT-SOFC the focus of many studies in the future.     

Single-switch boost-buck DC-DC converter for industrial fuel cell and photovoltaics applications

The realization of dc-dc converters performs a vital function in exploiting renewable energy sources such as solar photovoltaic (PV) and fuel cell applications. This paper demonstrates a single-switch unidirectional buck-boost dc-dc converter for continuous power flow control, excluding the hybrid switched-capacitor. The proposed converter utilizes a limited number of passive components, only four diodes and three inductors required, in addition to six capacitors. The converter can operate at a wide input voltage range with continues input current. The converter has experimented under real-time conditions with 660 W PV system. The obtained efficiency ranges from 93% to 98%. Furthermore, the converter has interfaced with 550 W fuel cell operated under different fuel pressure. The realized efficiency ranges from 91% to 97%. The maximum measured inductance current ripple is limited to under 0.70 A in both scenarios, whereas 0.16 V is the maximum output voltage ripple.     

Sintering behavior of BaCe0.7Zr0.1Y0.2O3-δ electrolyte at 1150 °C with the utilization of CuO and Bi2O3 as sintering aids and its electrical performance

BaCe_0.7Zr_0.1Y_0.2O_3-δ (BCZY) is one of the promising electrolytic candidate for solid oxide fuel cell (SOFC) due to its good proton conductivity and better stability. Herein, the effect of dual sintering aids such as CuO-Bi₂O₃ upon the sinterability at low temperature, improved electrochemical properties, and thermo-chemical changes about proton-conducting BaCe_0.7Zr_0.1Y_0.2O_3-δ electrolyte were investigated in detail. FESEM micrographs and shrinkage curves revealed significant improvement in sinterability and densifications of BCZY electrolyte. The dense pellets were sintered with CuO-Bi₂O₃ (2–3 mol %) as sintering aids at a temperature of 1150 °C for 5 h. The perfectly uniform distribution of sintering aids increased the linear shrinkage of BCZY from 5% till 19–21%. The crystallite size and grain growth within the structure was enhanced due to the formation of the melting phase of Bi₂O₃ and Cu²⁺ incorporation in the perovskite structure. The elevated and improved electrochemical measurement for BCZY with 2 mol% of CuO-Bi₂O₃ as sintering aid categorized it well suited for solid oxide fuel cells.     

A novel low power hybrid cache using GC-EDRAM cells

In a typical embedded CPU, large on-chip storage is critical to meet high performance requirements. However, the fast increasing size of the on-chip storage based on traditional SRAM cells makes the area cost and energy consumption unsustainable for future embedded applications. Replacing SRAM with DRAM on the CPU’s chip is generally considered not worthwhile because DRAM is not compatible with the common CMOS logic and requires additional processing steps beyond what is required for CMOS. However a special DRAM technology, Gain-Cell embedded-DRAM (GC-eDRAM)  [1], [2], [3] is logic compatible and retains some of the good properties of DRAM (small and low power). In this paper we evaluate the performance of a novel hybrid cache memory where the data array, generally populated with SRAM cells, is replaced with GC-eDRAM cells while the tag array continues to use SRAM cells. Our evaluation of this cache demonstrates that, compared to the conventional SRAM-based designs, our novel architecture exhibits comparable performance with less energy consumption and smaller silicon area, enabling the sustainable on-chip storage scaling for future embedded CPUs.     

Structure–Function Relationship of Retinal Ganglion Cells in Multiple Sclerosis

The retinal ganglion cells (RGC) may be considered an easily accessible pathophysiological site of degenerative processes in neurological diseases, such as the RGC damage detectable in multiple sclerosis (MS) patients with (HON) and without a history of optic neuritis (NON). We aimed to assess and interrelate RGC functional and structural damage in different retinal layers and retinal sites. We included 12 NON patients, 11 HON patients and 14 healthy controls for cross-sectional multifocal pattern electroretinography (mfPERG) and optical coherence tomography (OCT) measurements. Amplitude and peak times of the mfPERG were assessed. Macula and disc OCT scans were acquired to determine macular retinal layer and peripapillary retinal nerve fiber layer (pRNFL) thickness. In both HON and NON patients the foveal N2 amplitude of the mfPERG was reduced compared to controls. The parafoveal P1 peak time was significantly reduced in HON only. For OCT, parafoveal (pfGCL) and perifoveal (pGCL) ganglion cell layer thicknesses were decreased in HON vs. controls, while pRNFL in the papillomacular bundle sector (PMB) showed reductions in both NON and HON. As the mfPERG derived N2 originates from RGC axons, these findings suggest foveal axonal dysfunction not only in HON, but also in NON patients.     

Liver-Resident Memory CD8+ T Cells: Possible Roles in Chronic HBV Infection

Achieving a functional cure for chronic hepatitis B virus (HBV) infection or complete elimination of HBV covalently closed circular DNA (cccDNA) has been challenging in the treatment of patients with chronic HBV infection. Although novel antivirals are being investigated, improving HBV-specific adaptive immune responses is also important for durable viral clearance. Tissue-resident memory CD8⁺ T (T_RM) cells were recently reported as a T-cell population that resides in peripheral tissues and does not recirculate. T_RM cells have been studied in the livers of mice and humans. Liver T_RM cells have distinct characteristics compared to T cells in peripheral blood or other tissues, which may be associated with the unique microenvironment of the liver. In this review, we describe the characteristics of liver T_RM cells and their implications in chronic HBV infection. We emphasize that liver T_RM cells can be an immunotherapeutic target for the treatment of chronic HBV infection.     

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

Lung cancer is one of the most common malignant neoplasms. As a result of the disease’s progression, patients may develop metastases to the central nervous system. The prognosis in this location is unfavorable; untreated metastatic lesions may lead to death within one to two months. Existing therapies—neurosurgery and radiation therapy—do not improve the prognosis for every patient. The discovery of Epidermal Growth Factor Receptor (EGFR)—activating mutations and Anaplastic Lymphoma Kinase (ALK) rearrangements in patients with non-small cell lung adenocarcinoma has allowed for the introduction of small-molecule tyrosine kinase inhibitors to the treatment of advanced-stage patients. The Epidermal Growth Factor Receptor (EGFR) is a transmembrane protein with tyrosine kinase-dependent activity. EGFR is present in membranes of all epithelial cells. In physiological conditions, it plays an important role in the process of cell growth and proliferation. Binding the ligand to the EGFR causes its dimerization and the activation of the intracellular signaling cascade. Signal transduction involves the activation of MAPK, AKT, and JNK, resulting in DNA synthesis and cell proliferation. In cancer cells, binding the ligand to the EGFR also leads to its dimerization and transduction of the signal to the cell interior. It has been demonstrated that activating mutations in the gene for EGFR-exon19 (deletion), L858R point mutation in exon 21, and mutation in exon 20 results in cancer cell proliferation. Continuous stimulation of the receptor inhibits apoptosis, stimulates invasion, intensifies angiogenesis, and facilitates the formation of distant metastases. As a consequence, the cancer progresses. These activating gene mutations for the EGFR are present in 10–20% of lung adenocarcinomas. Approximately 3–7% of patients with lung adenocarcinoma have the echinoderm microtubule-associated protein-like 4 (EML4)/ALK fusion gene. The fusion of the two genes EML4 and ALK results in a fusion gene that activates the intracellular signaling pathway, stimulates the proliferation of tumor cells, and inhibits apoptosis. A new group of drugs—small-molecule tyrosine kinase inhibitors—has been developed; the first generation includes gefitinib and erlotinib and the ALK inhibitor crizotinib. These drugs reversibly block the EGFR by stopping the signal transmission to the cell. The second-generation tyrosine kinase inhibitor (TKI) afatinib or ALK inhibitor alectinib block the receptor irreversibly. Clinical trials with TKI in patients with non-small cell lung adenocarcinoma with central nervous system (CNS) metastases have shown prolonged, progression-free survival, a high percentage of objective responses, and improved quality of life. Resistance to treatment with this group of drugs emerging during TKI therapy is the basis for the detection of resistance mutations. The T790M mutation, present in exon 20 of the EGFR gene, is detected in patients treated with first- and second-generation TKI and is overcome by Osimertinib, a third-generation TKI. The I117N resistance mutation in patients with the ALK mutation treated with alectinib is overcome by ceritinib. In this way, sequential therapy ensures the continuity of treatment. In patients with CNS metastases, attempts are made to simultaneously administer radiation therapy and tyrosine kinase inhibitors. Patients with lung adenocarcinoma with CNS metastases, without activating EGFR mutation and without ALK rearrangement, benefit from immunotherapy. This therapeutic option blocks the PD-1 receptor on the surface of T or B lymphocytes or PD-L1 located on cancer cells with an applicable antibody. Based on clinical trials, pembrolizumab and all antibodies are included in the treatment of non-small cell lung carcinoma with CNS metastases.